
Industry
Is Jounce Therapeutics Inc. (JNCE) a good stock to buy now?
Jounce Therapeutics Inc. (NASDAQ: JNCE) is 10.81% higher on its value in year-to-date trading and has touched a low of $0.58 and a high of
Jounce Therapeutics Inc. (NASDAQ: JNCE) is 10.81% higher on its value in year-to-date trading and has touched a low of $0.58 and a high of
Jounce Therapeutics Inc. (NASDAQ: JNCE) is 9.91% higher on its value in year-to-date trading and has touched a low of $0.58 and a high of
Jounce Therapeutics Inc. (NASDAQ: JNCE) is -88.18% lower on its value in year-to-date trading and has touched a low of $0.58 and a high of
Following an amendment in a strategic agreement, shares of Jounce Therapeutics Inc. (JNCE) increased 59.75% to $1.18 on Wednesday. Which agreement has JNCE amended? In
Jounce Therapeutics Inc. (NASDAQ: JNCE) is -91.22% lower on its value in year-to-date trading and has touched a low of $0.58 and a high of